Additional Resources Will Drive Commercialization of Novel High-Throughput Label-Free Biosensor for Streamlined Antibody Characterization   Salt Lake City, Utah, USA…Carterra

AUSTIN, Texas– Asuragen, Inc., a global molecular diagnostics product company changing the way patients are treated in genetics and oncology

October 24, 2017 Ann Arbor, MI: Aquaro Histology, Inc. (formerly known as Aquaro Biosystems, LLC) announced today the completion of

San Diego, CA, September 27, 2017 – Agena Bioscience today announced a comparative study published in PLOS ONE highlighting the

TrakCel Solution will electronically link Iovance with clinical sites, contract manufacturing organizations and couriers to schedule and track TIL therapies

TrakCel solution integration with Cell and Gene Therapy Catapult manufacturing centre enables needle-to-needle supply chain management at any scale London,

Seattle, WA, August 24, 2017 – RareCyte, Inc., a global rare cell detection and liquid biopsy company will use the

San Diego–(BUSINESS WIRE)—August 24, 2017– Illumina Inc. (NASDAQ: ILMN) today announced plans with Telegraph Hill Partners (THP), a San Francisco-based

San Diego, CA, August 2, 2017– Agena Bioscience has entered into a 3-year agreement with the Illinois Department of Public

AUSTIN, Texas–(BUSINESS WIRE)– Asuragen, Inc., a molecular diagnostics company changing the way diagnostics impact patient care in genetics and oncology,